Cookies need to be enabled on your browser for this site to work properly. Please enable cookies before proceeding. More details
This site is optimized for Firefox (v1.x), Internet Explorer (v6.x), Chrome (v0.x), Safari (v3.x) and Netscape (v7.x) on Windows and Firefox (v1.x), Netscape (v7.x) and Safari (1.3) on the Macintosh.More details
JavaScript needs to be enabled on your browser for this site to work properly. Please enable JavaScript before proceeding. More details
 
Contact Us | Help  
LOGIN HERE [ REGISTER ]
Remember Me
 
15 stories
Also Available:
52 video clips
115 still images
Stories per page:
      Page  1  of  2    next page 
Image
First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the risk of malaria by half in African... [Source:GlaxoSmithKline]
First results from a large-scale Phase III trial of RTS,S, published online today in the New England... More 
  (10)
  (16)
Image
Transforming GSK's Headquarters in support of London 2012 Olympic & Paralympic Games [Source:GlaxoSmithKline]
London 2012 provider, GlaxoSmithKline, unveils sign celebrating its scientific contribution to the Games.... More 
  (1)
Image
GlaxoSmithKline receives FDA approval for BOOSTRIX® to help prevent whooping cough in adults 65 years and older [Source:GlaxoSmithKline]
The U.S. Food and Drug Administration (FDA) has approved BOOSTRIX® [Tetanus Toxoid, Reduced Diphtheria... More 
  (4)
Image
GlaxoSmithKline & Liberty/Synterra Break Ground on Five Crescent Drive at The Philadelphia Navy Yard [Source:GlaxoSmithKline]
Just four months after executing an agreement to build "the workplace of the future" at The Navy Yard... More 
  (1)
  (7)
Image
Our Commitment to Fighting Malaria [Source:GlaxoSmithKline]
On this day we recognise the global effort to provide effective control of malaria – a life-threatening... More 
  (1)
Image
GlaxoSmithKline and XenoPort receive FDA approval for Horizant™ [Source:GlaxoSmithKline]
GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) announced Wednesday that the U.S. Food and... More 
  (1)
  (1)
Image
Human Genome Sciences and Glaxosmithkline Announce FDA Approval of BENLYSTA® (Belimumab) for Treatment of Systemic Lupus Erythem... [Source:GlaxoSmithKline]
Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) today announced that the U.S.... More 
  (1)
Image
GlaxoSmithKline Releases 2010 Annual Report [Source:GlaxoSmithKline]
GSK released its Annual Report for 2010. As part of its corporate reporting process, the company has... More 
  (10)
Image
GSK Offers Free Vaccines to Uninsured Adults [Source:GlaxoSmithKline]
GlaxoSmithKline (NYSE: GSK) today announced the launch of the GSK Vaccines Access Program, which will... More 
  (6)
      Page  1  of  2    next page